Apolipoproteins as markers and managers of coronary risk by D.C. Chan, and G.F. Watts QJM Volume 99(5): April 24, 2006 © The Author Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please
Schematic summary of the endogenous pathways of the atherogenic and anti-atherogenic lipoproteins. D.C. Chan, and G.F. Watts QJM 2006;99: © The Author Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please
Low-density lipoprotein particle number, size and composition in different metabolic states: (A) familial hypercholesterolaemia; (B) normolipidaemia; and (C) metabolic syndrome. D.C. Chan, and G.F. Watts QJM 2006;99: © The Author Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please
Effect of atorvastatin on LDL cholesterol (A) and apoB levels (B) in the ACCESS study (reference 40). D.C. Chan, and G.F. Watts QJM 2006;99: © The Author Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please